In another study, these authors demonstrated that fibroblast growth factor receptor 1 (FGFR1) amplification in brain metastases of adenocarcinomas – but not squamous cell carcinomas, is fivefold more frequent than reported for primary tumors (~3%). The gene discussed is FGFR1; the disease is adenocarcinoma.